Bio-Techne
TECH
#1489
Rank
NZ$20.22 B
Marketcap
$127.32
Share price
-1.45%
Change (1 day)
21.04%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) Fails to deliver data

Key failure to deliver metrics for Bio-Techne:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bio-Techne (TECH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014

Volume in USD (price x number of shares), data since 2014

Bio-Techne (TECH) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$28.79 M-32.68%
2023NZ$42.76 M-15.62%
2022NZ$50.68 M-42.56%
2021NZ$88.22 M200.19%
2020NZ$29.39 M124.27%
2019NZ$13.1 M90.7%
2018NZ$6.87 M-5.05%
2017NZ$7.23 M-54.94%
2016NZ$16.06 M17.78%
2015NZ$13.63 M342.13%
2014NZ$3.08 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$12.31 MNZ$0.28 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.13 MNZ$14.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.24 MNZ$71.21 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$77.17 MNZ$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/ANZ$4.93 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$0.17 BNZ$1.34 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.01 MNZ$0.05 M๐Ÿ‡บ๐Ÿ‡ธ USA